Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Brethol
Brethol (Salbutamol Inhaler) is a fast-acting bronchodilator designed to provide immediate relief from asthma attacks, bronchospasm, and breathing difficulties caused by chronic respiratory conditions. As a short-acting β2-adrenergic agonist (SABA), Salbutamol quickly relaxes airway muscles, allowing for easier breathing. It is widely prescribed for individuals with asthma, chronic obstructive pulmonary disease (COPD), and exercise-induced bronchospasm.
Uses of Brethol
Relief of Acute Asthma Attacks
Management of Chronic Asthma and COPD
Prevention of Exercise-Induced Bronchospasm
Treatment of Airway Obstruction in Respiratory Diseases
Benefits of Brethol
Rapid Bronchodilation Within Minutes
Immediate Relief from Breathlessness and Wheezing
Portable and Easy-to-Use Inhaler for On-the-Go Treatment
Reduces the Risk of Severe Asthma Attacks
Clinically Proven Safety and Efficacy in Airway Disorders
Mechanism of Action of Brethol
Brethol contains Salbutamol, a β2-adrenergic agonist that binds to β2-receptors in the airway smooth muscles, leading to muscle relaxation and bronchodilation. This action reduces airway resistance, allowing for improved oxygen flow and immediate symptom relief. The inhaler delivers the medication directly to the lungs, ensuring quick onset of action with minimal systemic effects.